Igniting the Future of Drug Discovery
AI-Powered Insights • Automation-Powered Genomics • Faster Results
Drug Discovery Is Broken
Traditional discovery services are expensive, require specialized expertise, and too often fail to deliver. The numbers tell the story: preclinical false discovery rates exceed 85%. Non-causal protein pairings waste resources. Target validation failures derail programs. And off-target effects continue to cause late-stage attrition.
The root cause? Inadequate mechanism of action characterization. Low confidence in on- and off-target validation. Siloed insights that never connect across discovery stages.
There's a better way.
One Platform. Complete Answers.
The Embyr Discovery Engine integrates knowledge graphs, deep probabilistic models, AI algorithms, and a modular CRISPR toolkit into a single, powerful platform. We don't just generate data—we deliver validated targets with complete mechanism insights.
Automation excellence
Advanced robotic systems and AI-driven workflows enable high-throughput processing with unprecedented precision and reproducibility.
Massive scale
Industry-leading capacity to process 10,000+ samples simultaneously, supporting the largest genomic studies and screens.
Rapid Turnaround
Optimized pipelines deliver results in 48-72 hours rather than weeks, accelerating your research timeline significantly.